Thursday, February 2, 2023
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PROGRAM OVERVIEW
This educational activity will assist the target HCP’s ability to: assess the clinical advantages and disadvantages associated with leutinizing hormone-releasing hormone (LHRH) agonists and gonadotropin-releasing hormone (GnRH) antagonists used as androgen deprivation therapy (ADT) for patients with advanced prostate cancer (PC); evaluate the differential level of risk for cardiovascular adverse events when selecting ADT for patients with advanced PC; support equitable PC care through improved access to ADT and, finally, improve adherence to ADT through consideration of patient preferences regarding the route of administration.
PRESENTING FACULTY
Alicia K. Morgans, MD, MPH
Genitourinary Medical Oncologist
Dana-Farber Cancer Institute
Boston, MA
TARGET AUDIENCE
This activity is intended for U.S.-based urologists, medical oncologists, radiation oncologists, nurse practitioners, physician assistants, pharmacists, and other allied PC healthcare providers involved in the management of patients with PC.
EDUCATIONAL OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the clinical advantages and disadvantages associated with LHRH agonists and GnRH antagonists used as ADT for patients with advanced PC
- Evaluate the differential level of risk for cardiovascular adverse events when selecting ADT for patients with advanced PC
- Support equitable PC care through improved access to ADT
- Improve adherence to ADT through consideration of patient preferences regarding route of administration
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with advanced prostate cancer.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
